Axon's evolution from a simple TASER manufacturer into a leader in public safety technology has been very impressive. Read ...

Axon Enterprise (AXON) is jumping 17% after the company reported higher-than-expected fourth-quarter earnings per share and provided 2025 revenue guidance that also came in above analysts' average ...

Robert John, an itinerant singer-songwriter who was working in construction before scoring a Number One hit with 1979’s “Sad Eyes,” died Monday. He was 79. Michael Pedrick, John’s son ...

Aerospace and defense company AXON (NASDAQ:AXON) will be reporting results tomorrow after market hours. Here’s what to expect. Axon beat analysts’ revenue expectations by 3.6% last quarter ...

The Hendershot Generator boasts a compact and lightweight design, making it easy to install in various locations, whether in a basement, garage, or backyard. Its portability means you can move it ...

We recently published a list of Jim Cramer and Analysts Like These 10 Stocks. In this article, we are going to take a look at ...

John Oliver, host of "Last Week Tonight" on HBO, is a 21-time Emmy winner. But he still remembers how frequently he bombed as a young comedian in the U.K. When he was starting out, Oliver used to ...

AXON was trading ~10% down Wednesday afternoon at $640.15. "Shares are up 20% year-to-date and trading at valuations that are lofty, by any metric," said the research note.

John earned a Grammy nomination for "Sad Eyes" Michael Ochs Archives/Getty Robert John, the singer-songwriter behind the chart-topping hit "Sad Eyes," has died. He was 79. John's son Michael ...

Axon Enterprise is a market leader in public safety technologies, with products ranging from Taser devices to body cameras and cloud solutions for law enforcement agencies. In recent years ...

Argus analyst John Staszak published new coverage on Axon yesterday, maintaining a buy rating on the stock but lowering his one-year price target from $800 per share to $700 per share. As of this ...

Axon Enterprise handily beat fourth-quarter expectations on the top and bottom lines. The company's contracted backlog was impressive and its full-year 2025 guidance exceeded estimates. Axon has a ...